Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
07/13/23 • 13 min
Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content:
Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content:
Previous Episode
Predictive Value of Parafoveal Diabetic Macular Ischemia for Diabetic Retinal Disease Progression and VA Deterioration
Interview with Carol Y. Cheung, PhD, author of Assessment of Parafoveal Diabetic Macular Ischemia on Optical Coherence Tomography Angiography Images to Predict Diabetic Retinal Disease Progression and Visual Acuity Deterioration. Hosted by Neil Bressler, MD. Related Content:
Next Episode
Assessing Strategies to Reduce Carbon Footprint of the AAO Annual Meeting
Interview with Scott M. McClintic, MD, author of Assessing Strategies to Reduce the Carbon Footprint of the Annual Meeting of the American Academy of Ophthalmology. Hosted by Neil Bressler, MD. Related Content:
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/jama-ophthalmology-author-interviews-8989/low-dose-001-atropine-eye-drops-vs-placebo-for-myopia-control-31550564"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to low-dose 0.01% atropine eye drops vs placebo for myopia control on goodpods" style="width: 225px" /> </a>
Copy